Immunization financing

In accordance with past trends, immunization spending continues to rise. In 2012, routine immunization spending in low- and middle-income countries reached US$20 per surviving infant. The introduction of new, more expensive vaccines is contributing to this increase. However, due to strong economic growth in the developing countries, the prospect of additional domestic financing for immunization programs is receiving attention. A number of countries are now approaching the thresholds for graduation of support from Gavi, the Vaccine Alliance, leading to discussions of how to best prepare for self-sufficiency. Meanwhile, donors continue to show strong support for immunization. For instance, Gavi’s January 2015 pledging conference raised more than $7.5 billion for the 2016 to 2020 period. In spite of these successes, income growth and access to immunization services are not uniformly distributed across the world or within countries. Equitable coverage and reaching the poorest will remain challenges to be confronted in the coming years. As a result, immunization financing is a critical tool for providing access to lifesaving vaccines to those who need them most.

View resources on immunization financing

Page last updated: February 2016.

Photo: PATH/Amy MacIver.